Abstract
Fifteen xanthates with carbon chains of different lengths or substitutions, including the antiviral compound D609 (O-tricyclo[5.2.1.02,6]dec-9-yl-dithiocarbonate), were tested for their ability to inactivate cytochromes P-450 (P-450s) 2B1 and 2B6. All of the xanthates tested were found to inactivate P-450 2B1 in a time- and concentration-dependent manner. The rates of inactivation at 30°C ranged from 0.22 min−1 to 0.02 min−1. The concentrations required for half-maximal inactivation were between 2.4 and 69 μM. A general trend in the inactivation kinetics could be observed with an increasing chain length of the xanthates. Longer carbon chains resulted in slower rates of inactivation with longer half-times of inactivation and higher partition ratios. For P-450 2B1, the most effective inactivators were xanthates with substitutions of intermediate length. The best inactivator for P-450 2B1 was the C8 xanthate, with an inactivation potency (KI) of 2.4 μM, a rate of inactivation of 0.07 min−1, and a partition ratio of 4. Four xanthates were further examined for their effect on the 7-ethoxy-4-(trifluoromethyl)coumarin activity of P-450 2B6. The C8 xanthate was again the most effective inactivator, with aKI of 1 μM. Although theKI values were generally lower than those found with P-450 2B1, the rates of inactivation for P-450 2B6 with the various xanthates were 3- to 5-fold slower. In addition, the isozyme selectivity of xanthates was tested with P-450s 2E1, 1A1, 3A2, 3A4, 2C9, and 2D6. P-450 2E1 was inactivated by xanthates at concentrations 15- to 100-fold higher than those required to inactivate either P-450 2B1 or 2B6. P-450 1A1 was not inactivated by xanthates. However, all of the xanthates tested were able to inhibit the enzymatic activity of P-450 1A1 to a different extent, depending on the length of the xanthate carbon chain. Virtually no inactivation of P-450s 2D6 or 2C9 was seen, except that C8 and D609 were inhibitory at high concentrations (0.2–0.6 mM). None of the xanthates studied had any effect on the activities of P-450s 3A2 or 3A4.
Footnotes
-
Send reprint requests to: Dr. Paul F. Hollenberg, Department of Pharmacology, Medical Science Research Bldg. III, 1150 West Medical Center Dr., Ann Arbor, Michigan. E-mail:phollen{at}umich.edu
-
This publication was supported in part by National Institutes of Health Grant CA 16954 (to P.F.H.) from the National Cancer Institute. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.
- Abbreviations used are::
- P-450
- cytochrome P-450
- P-450 2B1
- major form of P-450 from microsomes of phenobarbital-induced rats
- reductase
- NADPH-P-450 reductase
- 7-EFC
- 7-ethoxy-4-(trifluoromethyl)coumarin
- HFC
- 7-hydroxy4-(trifluoromethyl)coumarin
- DLPC
- dilauroyl-l-a-phosphatidylcholine
- D609
- O-tricyclo[5.2.1.02,6]dec-9-yl-dithiocarbonate
- Received November 9, 1998.
- Accepted January 29, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|